Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

90.07 +0.82 (+0.92%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
2 Dividend Stocks to Buy for a Lifetime of Passive Income
These are the kinds of stocks that can allow investors to sleep easy at night. 
Via The Motley Fool
Medtronic Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Via Benzinga
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon
Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy? 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
15 Analysts Assess Medtronic: What You Need To Know
Via Benzinga
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Peering Into Medtronic's Recent Short Interest
Via Benzinga
Medtronic Inc.: Dividend Stock Analysis
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management and other medical markets. 
Via Talk Markets
NYSE:MDT Shows Potential for a Breakout.
Good technical signals and a possible breakout for MEDTRONIC PLC. 
Via Chartmill
Universal Adhesive Patch For CGM And Insulin Pump
Via AB Newswire
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit 
Via News Direct
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
Via Talk Markets
Truffles Vein Specialists Expands with Newest Location at 5041 Dallas Hwy, Powder Springs, Georgia, Offering Advanced Vein Care
Truffles Vein Specialists opens a new clinic at 5041 Dallas Hwy, Powder Springs, delivering expert minimally invasive treatments for varicose veins, spider veins, and other vascular conditions. 
Via PRUnderground
The Smartest Dividend Stocks to Buy With $10,000 Right Now
If you have $10k today, while the market is at all-time highs, think about diversification and downside risk. 
Via The Motley Fool
Looking Into Medtronic's Recent Short Interest
Via Benzinga
Is Medtronic Stock a Buy?
It might not be the most exciting business, but it has other things going its way. 
Via The Motley Fool
Medtronic Analysts Boost Their Forecasts After Upbeat Earnings
Via Benzinga
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
Via MarketBeat
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200
Dividend income can be a great way to boost your portfolio growth. 
Via The Motley Fool
MarketBeat Week in Review – 9/9 - 9/13
Markets were mostly positive this week as benign inflation numbers did nothing to dampen expectations that the Federal Reserve will cut interest rates 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Top Stock Reports For Verizon, Prologis & Medtronic
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Prologis, Inc. (PLD), and Medtronic plc (MDT), as well as a micro-cap stock Crimson... 
Via Talk Markets
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic's stock has been rising higher in recent weeks after another solid quarterly performance. 
Via The Motley Fool
3M, Visa, Medtronic And More On CNBC's 'Final Trades'
Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts shared picks like Visa and Medtronic. 
Via Benzinga
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases 
Via MarketBeat
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?
Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know. 
Via The Motley Fool
MarketBeat Week in Review – 8/26 - 8/30
The major indexes moved between gains and losses to end the month, but the volatility may ramp back up with the release of the jobs report next Friday 
Via MarketBeat
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
Palo Alto and Cava were among the earnings winners. 
Via Investor's Business Daily
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance. 
Via MarketBeat
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.